T LYMPHOBLASTIC LYMPHOMA

Clinical trials for T LYMPHOBLASTIC LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new T LYMPHOBLASTIC LYMPHOMA trials appear

Sign up with your email to follow new studies for T LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 3 Not yet finished but already full! 1 Completed 1 Terminated 1

New drug combo for kids with tough leukemia shows promise but trial halted early

Disease control Terminated

This trial tested the drug isatuximab, a targeted antibody, combined with standard chemotherapy in children aged 28 days to under 18 years whose acute leukemia had returned or stopped responding to treatment. The study aimed to see if the combination could help more children achi…

Matched conditions: T LYMPHOBLASTIC LYMPHOMA

Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control

Last updated Jun 26, 2026 15:09 UTC

T LYMPHOBLASTIC LYMPHOMA

Get alerted when new T LYMPHOBLASTIC LYMPHOMA trials appear

New drug combo for kids with tough leukemia shows promise but trial halted early